147 related articles for article (PubMed ID: 16420518)
1. Effect of celecoxib on experimental liver fibrosis in rat.
Hui AY; Leung WK; Chan HL; Chan FK; Go MY; Chan KK; Tang BD; Chu ES; Sung JJ
Liver Int; 2006 Feb; 26(1):125-36. PubMed ID: 16420518
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes.
Wen SL; Gao JH; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
J Gastroenterol Hepatol; 2014 Nov; 29(11):1932-42. PubMed ID: 24909904
[TBL] [Abstract][Full Text] [Related]
3. Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.
Chávez E; Segovia J; Shibayama M; Tsutsumi V; Vergara P; Castro-Sánchez L; Salazar EP; Moreno MG; Muriel P
Liver Int; 2010 Aug; 30(7):969-78. PubMed ID: 20524983
[TBL] [Abstract][Full Text] [Related]
4. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
Planagumà A; Clària J; Miquel R; López-Parra M; Titos E; Masferrer JL; Arroyo V; Rodés J
FASEB J; 2005 Jul; 19(9):1120-2. PubMed ID: 15876570
[TBL] [Abstract][Full Text] [Related]
5. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.
Tu CT; Guo JS; Wang M; Wang JY
J Gastroenterol Hepatol; 2007 Jun; 22(6):877-84. PubMed ID: 17565644
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.
George J; Tsutsumi M
Gene Ther; 2007 May; 14(10):790-803. PubMed ID: 17344905
[TBL] [Abstract][Full Text] [Related]
9. [Effect of interferon-α on rat liver fibrosis induced by CCl(4)].
Li Y; Yang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):243-8. PubMed ID: 21464546
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
11. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
Kapoor S; Bahde R
Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
[No Abstract] [Full Text] [Related]
12. Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum.
Liu H; Wei W; Li X
Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):63-7. PubMed ID: 19007904
[TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
14. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress.
Su SC; Tanimoto K; Tanne Y; Kunimatsu R; Hirose N; Mitsuyoshi T; Okamoto Y; Tanne K
Osteoarthritis Cartilage; 2014 Jun; 22(6):845-51. PubMed ID: 24721459
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats.
Ekor M; Odewabi AO; Kale OE; Adesanoye OA; Bamidele TO
Drug Chem Toxicol; 2013 Jan; 36(1):1-8. PubMed ID: 22168377
[TBL] [Abstract][Full Text] [Related]
17. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.
Wang CH; Lee TH; Lu CN; Chou WY; Hung KS; Concejero AM; Jawan B
Gene Ther; 2006 Jul; 13(13):1000-9. PubMed ID: 16511523
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury.
Harris TR; Kodani S; Rand AA; Yang J; Imai DM; Hwang SH; Hammock BD
Mol Pharmacol; 2018 Aug; 94(2):834-841. PubMed ID: 29844231
[TBL] [Abstract][Full Text] [Related]
19. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation.
Chou WY; Lu CN; Lee TH; Wu CL; Hung KS; Concejero AM; Jawan B; Wang CH
Acta Pharmacol Sin; 2006 Apr; 27(4):469-76. PubMed ID: 16539848
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
Tian F; Zhang YJ; Li Y; Xie Y
PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
